TR200100290T2 - Transdermal hormon uygulaması için estradiol içerikli flaster - Google Patents

Transdermal hormon uygulaması için estradiol içerikli flaster

Info

Publication number
TR200100290T2
TR200100290T2 TR2001/00290T TR200100290T TR200100290T2 TR 200100290 T2 TR200100290 T2 TR 200100290T2 TR 2001/00290 T TR2001/00290 T TR 2001/00290T TR 200100290 T TR200100290 T TR 200100290T TR 200100290 T2 TR200100290 T2 TR 200100290T2
Authority
TR
Turkey
Prior art keywords
estradiol
active ingredient
containing patch
hormone administration
transdermal hormone
Prior art date
Application number
TR2001/00290T
Other languages
English (en)
Turkish (tr)
Inventor
Kirstgen Elvira
Meconi Reinhold
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200100290T2 publication Critical patent/TR200100290T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
TR2001/00290T 1998-07-29 1999-07-16 Transdermal hormon uygulaması için estradiol içerikli flaster TR200100290T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834006A DE19834006A1 (de) 1998-07-29 1998-07-29 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen

Publications (1)

Publication Number Publication Date
TR200100290T2 true TR200100290T2 (tr) 2001-07-23

Family

ID=7875612

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00290T TR200100290T2 (tr) 1998-07-29 1999-07-16 Transdermal hormon uygulaması için estradiol içerikli flaster

Country Status (14)

Country Link
EP (1) EP1100478A1 (xx)
JP (1) JP2002521426A (xx)
KR (1) KR20010072071A (xx)
CN (1) CN1310615A (xx)
AR (1) AR019948A1 (xx)
AU (1) AU762589B2 (xx)
BR (1) BR9912688A (xx)
CA (1) CA2338861A1 (xx)
DE (1) DE19834006A1 (xx)
IL (1) IL141032A0 (xx)
PL (1) PL345696A1 (xx)
TR (1) TR200100290T2 (xx)
WO (1) WO2000006130A1 (xx)
ZA (1) ZA200100721B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047906A (ja) * 2003-07-16 2005-02-24 Taisho Pharmaceut Co Ltd 外用消炎鎮痛剤組成物
KR100689534B1 (ko) * 2005-05-18 2007-03-02 삼성전자주식회사 휴대 단말기

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (xx) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
WO1995017896A1 (fr) * 1993-12-27 1995-07-06 Akzo Nobel N.V. Preparation pour absorption par voie percutanee
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
AR019948A1 (es) 2002-03-27
AU762589B2 (en) 2003-06-26
WO2000006130A1 (de) 2000-02-10
EP1100478A1 (de) 2001-05-23
CA2338861A1 (en) 2000-02-10
BR9912688A (pt) 2001-11-27
KR20010072071A (ko) 2001-07-31
CN1310615A (zh) 2001-08-29
IL141032A0 (en) 2002-02-10
AU5284299A (en) 2000-02-21
JP2002521426A (ja) 2002-07-16
PL345696A1 (en) 2002-01-02
ZA200100721B (en) 2002-05-27
DE19834006A1 (de) 2000-02-24

Similar Documents

Publication Publication Date Title
TR200100289T2 (tr) Transdermal hormon uygulaması için estradiol içerkli flaster
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
TR27992A (tr) Suda veya alkolde cözünebilen veya dagilabilen silikon asili termoplastik elastomerik kopolimerler ve bunlari iceren sac ve cilt bakim bilesimleri.
TR200100022T2 (tr) Steroidal olmayan, asit gruplu romatizma ilacı içeren lokal etkili flaster
MY106628A (en) Estrogen-containing active substance plaster
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
NO950051D0 (no) Plaster for lavtsmeltende og/eller flyktige aktive bestanddeler
DK0802789T3 (da) Estradiolholdigt plaster
KR950703972A (ko) 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템(transdermal administration system containing acetylsalicyliic acid for antithrombotic therapy and the prevention of cancer)
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
ES2118249T3 (es) Parche que contiene dexpanthenol para la aplicacion percutanea de hormonas esteroideas.
JP2004500353A5 (xx)
JP2002521427A5 (xx)
TR200100290T2 (tr) Transdermal hormon uygulaması için estradiol içerikli flaster
ATE214606T1 (de) Transdermales therapeutisches system mit dem wirkstoff scopolaminbase
EP0991404A1 (en) Device for delivery of dermatological ingredients
HUP0003347A2 (hu) Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz
RU2000126276A (ru) Лекарственный препарат для профилактики и/или лечения рака молочной железы, содержащий стероидный ингибитор ароматазы
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
AR029664A1 (es) Parche portador de estrngenos con reservorio de sustancia activa a base de etilcelulosa y un copolemero de etileno, acetato de vinilo y vinilpirrolidona
AR020108A1 (es) Preparado para la aplicacion terapeutica percutanea de trinitrato de glicerol, un procedimiento para su preparacion y su empleo
BR0302225A (pt) Aplicação para inibidores da aromatase ou bloqueadores de receptores de estradiol e seus derivados no tratamento de cloasma e melasma no ser humano
Holley Making it love
AR024199A1 (es) Uso de la buprenorfina en la preparacion de un disposotivo de suministro transdermico